Both in Pharmaceuticals
Sarepta Therapeutics, vs Zenas BioPharma
Over the past year SRPT returned −24.1% and ZBIO returned −7.9%; their daily moves had a correlation of 0.15.
SRPT −24.1% ZBIO −7.9%Growth of $1, one year, split-adjusted
| Metric | SRPT | ZBIO |
|---|---|---|
| Price | $18.56 | $28.87 |
| Market cap | $1.96B | $1.88B |
| Today | +1.31% | +4.53% |
| 1 month | +6.1% | +3.7% |
| 6 months | −14.8% | +39.1% |
| Year to date | −13.8% | −20.5% |
| 1 year | −22.7% | −7.6% |
| Revenue growth (YoY) | −34.3% | — |
| Gross margin | 62.8% | 100.0% |
| Net margin | −1.2% | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 1,881.7× |
| Net cash | -$59.1M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.6% | 56.4% |
| Short % of float | 22.7% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).